Patients with BRAFMUTTP53WT showed the highest level of tumor-infiltrating CD8+ T cells, patients with TP53MUTBRAFMUT or TP53WTBRAFWT showed moderate level of tumor-infiltrating CD8+ T cells, and patients with TP53MUTBRAFWT showed the lowest level of CD8+ T cells (Figure 3E). This evidence concerns the gene CD8A and neoplasm.